Combretazet-3 a novel synthetic cis-stable combretastatin A-4-azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer

Author：                

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.29, Iss.6, 2013-01, pp. : 2451-2458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro

By                

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 585-594

Spandidos Publications

Access to resources Recommend Favorite

Combretastatin A4 phosphate: a novel vascular disrupting agent

By Nagaiah Govardhanan   Remick Scot C  

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1219-1228

Future Medicine

Access to resources Recommend Favorite

Msi-1 is a Predictor of Survival and a Novel Therapeutic Target in Colon Cancer

By Li Dawei  

Annals of Surgical Oncology, Vol. 18, Iss. 7, 2011-07 ,pp. : 2074-2083

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo

By                    

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2275-2282

Spandidos Publications

Access to resources Recommend Favorite

ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models

By              

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1457-1468

Spandidos Publications

Access to resources Recommend Favorite